Clinical Trials Directory

Trials / Unknown

UnknownNCT03263325

Evaluation of UDP-glucose as a Urinary Biomarker for Early Detection of Cardiac Surgery-associated Pediatric Acute Kidney Injury

Status
Unknown
Phase
Study type
Observational
Enrollment
250 (estimated)
Sponsor
Boston Children's Hospital · Academic / Other
Sex
All
Age
8 Years
Healthy volunteers
Not accepted

Summary

Acute kidney injury (AKI) is common in children after cardiac surgery with a reported incidence of 20-40%. Pediatric AKI has been found to be associated with important short and long-term adverse outcomes. A major challenge to management of AKI after cardiac surgery and cardiopulmonary bypass is the lack of early diagnostic markers. Current diagnostic criteria for AKI in children relies exclusively on elevation of serum creatinine concentration and oliguria. Both of these markers lack sensitivity and specificity, and result in delayed detection of kidney injury. This study aims to determine if UDP-glucose can be used as a urinary biomarker to detect subclinical acute kidney injury following pediatric cardiac surgery with cardiopulmonary bypass.

Conditions

Interventions

TypeNameDescription
OTHERDiscarded urine sampleCollection of discarded urine during surgery and following surgery

Timeline

Start date
2017-10-25
Primary completion
2023-07-01
Completion
2023-08-01
First posted
2017-08-28
Last updated
2023-02-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03263325. Inclusion in this directory is not an endorsement.